Clinical Trial: A Novel Pathway to Detect Muscle-invasive Bladder Cancer Based on Integrated Clinical Features and VI-RADS Score on MRI

U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807008) titled 'A Novel Pathway to Detect Muscle-invasive Bladder Cancer Based on Integrated Clinical Features and VI-RADS Score on MRI' on Jan. 10.

Brief Summary: This study investigates the clinical, pathological, and radiological features, including the Vesical Imaging-Reporting and Data System (VI-RADS) score, that correlate with muscle-invasive bladder cancer (MIBC). It found that VI-RADS scores, along with other factors, were independent predictors of muscle invasiveness.

Study Start Date: Jan. 01, 2020

Study Type: OBSERVATIONAL

Condition: Muscle Invasive Bladder Cancer

Recruitment Status: COMPLETED

Sponsor: IRCCS Azienda Ospedaliero-Uni...